Direkt zum Inhalt
Merck
  • Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid.

Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid.

Neurochemistry international (2004-07-06)
P F Schuck, R B Rosa, L F Pettenuzzo, A Sitta, C M D Wannmacher, A T S Wyse, M Wajner
ZUSAMMENFASSUNG

Accumulation of methylmalonic acid (MMA) in tissues and biological fluids is the biochemical hallmark of patients affected by the neurometabolic disorder known as methylmalonic acidemia (MMAemia). Although this disease is predominantly characterized by severe neurological findings, the underlying mechanisms of brain injury are not totally established. In the present study, we investigated the effect of MMA, as well as propionic (PA) and tiglic (TA) acids, whose concentrations are also increased but to a lesser extend in MMAemia, on total (tCK), cytosolic (Cy-CK) and mitochondrial (Mi-CK) creatine kinase (CK) activities from cerebral cortex of 30-day-old Wistar rats. Total CK activity (tCK) was measured in whole cell homogenates, whereas Cy-CK and Mi-CK were determined, respectively, in cytosolic and mitochondrial preparations from rat cerebral cortex. We verified that tCK and Mi-CK activities were significantly inhibited by MMA at concentrations as low as 1 mM, in contrast to Cy-CK which was not affected by the presence of the acid in the incubation medium. Furthermore, PA and TA, at concentrations as high as 5 mM, did not alter CK activity. We also observed that the inhibitions provoked by MMA were fully prevented by pre-incubation of the homogenates with reduced glutathione, suggesting that the inhibitory effect of MMA was possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of CK for brain metabolism homeostasis, our results suggest that inhibition of this enzyme by increased levels of MMA may contribute to the neurodegeneration of patients affected by MMAemia and explain previous reports showing an impairment of brain energy metabolism and a reduction of brain phosphocreatine levels caused by MMA.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
trans-2-Methyl-2-Butensäure, ≥99%, FG
Sigma-Aldrich
trans-2,3-Dimethylacrylsäure, 98%